Article By:
StockNews
Saturday, May 22, 2021 4:20 PM EDT
The integration of technology and successful clinical trials for treating critical ailments have boosted Wall Street’s optimism about several biotech stocks. Analysts expect Bionano, Cerus, Agenus and VBI to gain by more than 60% in the near term.
Here's What Markets Have Missed By Overlooking The VBI Vaccines CMV News
What'd you hear about them? Any insider tips? ;-) $VBIV
Here's What Markets Have Missed By Overlooking The VBI Vaccines CMV News
Sci-B-Vac has been in my news feed for a while. I remember the first time I heard of it was at a cocktail party last year. What surprises me is that $VBIV has made remarkable progress on this drug. I think I need to pay it forward and tell my friends about its coming clinic trials this year.
VBI Vaccines: Hidden Vaccine Gem
@[Grayson Brown](user:49500) and @[Samuel Kaufman](user:49499), you left very similar comments at the same time. Same person perhaps trying to pump up this stock? $VBIV
VBI Vaccines: Hidden Vaccine Gem
Cool. This is a very informative article which deserves a better publicity. I would like to see how their Phase III trials go. Probably a good time to buy and hold. Maybe? $VBIV
VBI Vaccines: Hidden Vaccine Gem
I have been an investing veteran of #pharma companies for years. For the first time, I am truely amazed by the scale of the trials #VBI has been conducting. $VBIV